Drug Type Small molecule drug |
Synonyms + [2] |
Target |
Action inhibitors |
Mechanism BET inhibitors(Bromodomain and extra terminal domain protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | China | 07 Apr 2022 | |
Multiple Myeloma | Preclinical | China | 07 Apr 2022 | |
Myelofibrosis | Preclinical | China | 07 Apr 2022 | |
Triple Negative Breast Cancer | Preclinical | China | 07 Apr 2022 | |
Prostatic Cancer | Preclinical | China | 21 Aug 2020 |